Brief: Helius Medical Technologies Reports Q2 2022 Results
Aug 15 (Reuters) - Helius Medical Technologies Inc HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES, INC. REPORTS SECOND QUARTER
2022
FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.97
* TOTAL REVENUE FOR Q2 OF 2022 WAS $119 THOUSAND
Source text for Eikon: ID:nGNX5KWwnh
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit